Umoja Biopharma
PrivateLast Round
IPO
Apr 9, 2026
Est. Valuation
$420M
Total Funding Raised
$373M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Umoja Biopharma is a biotechnology company that develops in vivo immunotherapies to reprogram a patient's immune system to fight cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Umoja Biopharma Comparables
Compare Umoja Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CREATE Medicines | 83% | |
| AbbVie | 81% | |
| Sana Biotechnology | 79% | |
Umoja Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Apr 9, 2026 | ||||
| Series C | Jan 14, 2025 | ||||
| Seed | Jan 9, 2024 | ||||
| Series B | Jun 15, 2021 | ||||
| Series A | Nov 18, 2020 | ||||
Seed | Nov 21, 2019 |
Umoja Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MPM Capital | Series B, Seed, Series C, Series A |
| SoftBank Investment Advisers | Series C, Series B |
| Temasek | Series B |
| DCVC Bio | Series B, Seed, Series A, Series C |
| Cormorant Asset Management | Series C, Series B |
| Psalion VC | Seed |
| Orange DAO | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
Completed an IPO round of funding.
- Apr 9, 2026
Opened a new cell/gene therapy GMP manufacturing facility in Louisville, CO.
Umoja Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Umoja Biopharma's valuation, stock price, and market status.